期刊文献+

水飞蓟宾对人膀胱癌细胞株5637增殖的抑制作用及其机制 被引量:3

Effect of silibinin on proliferation of human bladder cancer cell 5637 in vitro and related mechanism
下载PDF
导出
摘要 目的研究水飞蓟宾(Silibinin,SB)在体外对人膀胱癌细胞株5637增殖的抑制作用及其相关机制。方法采用MTT法观察不同浓度SB对人膀胱癌细胞株5637增殖的抑制作用;倒置显微镜下观察细胞形态变化;RT-PCR检测凋亡抑制因子Survivin的mRNA表达变化。结果MTT检测发现:随着SB浓度增加和作用时间延长,对人膀胱癌细胞株5637增殖的抑制作用增强,且各组间比较均有显著性差异(P<0.01),并呈时间-剂量依赖关系;倒置显微镜发现应用SB干预后,5637细胞体积缩小,变形,胞浆浓缩,核固缩深染;人膀胱癌细胞株5637中Survivin的mRNA表达随着SB浓度增加和时间延长相应下降。结论SB可抑制人膀胱癌细胞株5637的增殖;并下调凋亡抑制因子Survivin的mRNA表达。 Objective To determine the effects of silibinin on inhibiting the proliferation of 5637 cell in vitro and to investigate the related mechanism. Methods The cell growth activity was evaluated by MTT assay. Morphological changes were studied through the inverted phase contrast microscope. The expression of survivin (inhibitor of apoptosis protein) mRNA was determined by reverse transcription-polymerase chain reaction (RT- PCR). Results Silibinin treatment of 5637 cells resulted in a moderate to strong growth inhibition in both a doseand a time-dependent manner. There were significant differences between these groups (P 〈 0. 01 ). These morphological changes of 5637 which were treated with silibinin: cells shrank and turned round, condensed cytoplasma and pycnosised nucleus were observed through the inverted phase contrast microscope. There was also significant difference in the positive expression of survivin mRNA between the 5637 cell treated by differentiated silibinin. Oonclusion Silibinin could inhibit the growth of human bladder cancer 5637 cells and down-regulate the expression of survivin.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2007年第5期559-562,共4页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 教育部骨干教师基金资助(No.教技司[00]143号)
关键词 水飞蓟宾 膀胱癌 增殖 SURVIVIN 人膀胱癌细胞株5637 silibinin carcinoma bladder cancer proliferation survivin 5637 cell line
  • 相关文献

参考文献10

  • 1吴阶平,顾方六,郭应禄,等.吴阶平泌尿外科学[M].山东:山东科学技术出版社,2004:965-966.
  • 2Laufer M,Ramalingam S,Schoenberg MP,et al.Intravesical gemcitabine therapy for superficial transitional cell carcinoma of the bladder:a phase Ⅰ and pharmacokinetic study[J].J Clin Oncol,2003,21(4):697-703.
  • 3Dalbagni G,Herr HW.Current use and questions concerning intravesical bladder cancer group for superficial bladder cancer[J].Urol Clin North Am,2000,27(1):137-146.
  • 4Sridar C,Goosen TC,Kent UM,et al.Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases[J].Drug Metab Dispos,2004,32:587-594.
  • 5Singh RP,Agarwal R.Prostate cancer prevention by silibinin[J].Curr Cancer Drug Targets,2004,4(1):1-11.
  • 6Agarwal C,Singh RP,Dhanalakshmi S,et al.Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT229 cells[J].Oncogene,2003,22(51):8271-8282.
  • 7Tyagi AK,Agarwal C,Singh RP,et al.Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladdert ransitional-cell papilloma RT4 cells[J].Biochem Biophys Res Commun,2003,312(4):1178-1184.
  • 8Flaig TW,Gustafson DL,Su JL,et al.A phase Ⅰ and pharmacokinetic study of silybin-phytosome in prostate cancer patients[J].Invest New Drugs,2007,25(2):139-146.
  • 9范引侠,薛翔,主改侠.凋亡调控因子Survivin和Caspase-3在子宫内膜癌中的表达及意义[J].西安交通大学学报(医学版),2007,28(1):93-96. 被引量:10
  • 10Suzuki A,Ito K,Kawano H,et al.Survivin initiates procaspase 3/p21 complex formation as a result of interaction with CDK4 to resist Fas-me diated cell death[J].Oncogene,2000,19(10):1346-1353.

二级参考文献11

  • 1史惠蓉,陈志敏,梁爱青.子宫内膜癌组织中Survivin和PCNA的表达[J].郑州大学学报(医学版),2005,40(3):408-410. 被引量:6
  • 2Tamm I,Wang Y,Sausville E,et al.IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas(CD95),Bax,Caspase,and anticancer drugs[J].Cancer Res,1998,58(23):315-5320.
  • 3Peiro G,Diebold J,Baretton GB,et al.Cellular apoptosis susceptibility gene expression in endometrial carcinoma:correlation with Bcl-2,Bax,Caspase-3 expression and outcome[J].Int J Gynecol Pathol,2001,20(4):359-367.
  • 4Shin S,Sung BJ,Cho YS,et al.An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7[J].Biochemistry,2001,40(4):1117-1123.
  • 5Ito T,Shirak K,Sugimoto K,et al,Survivin promotes cell proliferation in human hepatocelluar carcinoma[J].Hepatology,2000,31(5):1080-1085.
  • 6Mirzy A,McGuirk M,Hockenberry TN,et al.Human survivin is negatively regulated by wild-type P53 and participates in P53-dependent apoptotic pathway[J].Oncogene,2002,21 (17):2613-2622.
  • 7Koch CA,Vortmeyer AO,Diallo R,et al.Survivin:a novel neuroendocrine marker for pheochromocytoma[J].Eur J Endocrinol,2002,146(3):381-388.
  • 8Ikeguchi M,Ueda T,Sakatani T,et al.Expression of surviving messenger RNA correlates with poor prognosis in patient with hepatocellular carcinoma[J].Diagn Mol Pathol,2002,11 (1):33-40.
  • 9Chakravarti A,Noll E,Black PM,et al.Quantitatively determined survivin expression levels are of prognostic value in human gliomas[J].J Clin Oncol,2002,20(4):1063-1068.
  • 10Takai N,Miyazaki T,Nishida M,et al.Survivin expression correlates with clinical stage,histological grade,invasive behaviorand survival rate in endometrial carcinoma[J].Cancer Lett,2002,184(1):105-116.

共引文献62

同被引文献55

  • 1任孟军,左国庆,何松.水飞蓟宾对人肝癌细胞株HepG2增殖的影响及其机制研究[J].重庆医学,2005,34(3):369-370. 被引量:5
  • 2周蓓,吴立军,田代真一,小野寺敏,内海文彰,池岛乔.水飞蓟宾对异丙肾上腺素引起的大鼠乳鼠心肌细胞损伤的保护作用及其机制[J].药学学报,2007,42(3):263-268. 被引量:11
  • 3吴阶平.吴阶平泌尿外科学[M].山东科学技术出版社,2004,1:1059-1091
  • 4Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011 : the impact of eliminating socioeconomic and racial disparities on prema- ture cancer deaths[J]. CA Cancer J Clin, 2011, 61 (4) :212 - 236.
  • 5Stenzl A, Cowan NC, De Santis M, et al. The updated EAU guidelines on muscle - invasive and metastatic bladder cancer[ J 1. Eur Urol, 2009, 55(4) :815 -825.
  • 6Gupta S, Mahipal A. Role of systemic chemotherapy in urothelial u- rinary bladder cancer [ J ]. Cancer Control, 2013, 20 ( 3 ) : 200 - 210.
  • 7Meeks JJ, Bellmunt J, Bochner BH, et al. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle - invasive blad- der cancer[J]. Eur Urol, 2012, 62(3) :523 -533.
  • 8Eldefrawy A, Soloway MS, Katkoori D, et al. Neoadjuvant and ad- juvant chemotherapy for muscle - invasive bladder cancer: The likelihood of initiation and completion[J]. Indian J Urol, 2012. 28 (4) : 424 - 426.
  • 9Pouessel D, Mongiat- Artus P, Culine S. Neoadjuvant chemother- apy in muscle - invasive bladder cancer: ready for prime time? [J]. Crit Rev Oncol Hematol, 2013, 85(3) :288 -294.
  • 10Apolo AB, Grossman HB, Bajorin D, et al. Practical use of perio- perative chemotherapy for muscle - invasive bladder cancer: sum- mary of session at the Society of Urologic Oncology annual meeting [J]. Urol Oncol, 2012, 30(6) :772 -780.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部